Eric Mabery

813 total citations
17 papers, 459 citations indexed

About

Eric Mabery is a scholar working on Infectious Diseases, Hepatology and Molecular Biology. According to data from OpenAlex, Eric Mabery has authored 17 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Eric Mabery's work include Hepatitis C virus research (7 papers), HIV/AIDS drug development and treatment (7 papers) and Hepatitis B Virus Studies (3 papers). Eric Mabery is often cited by papers focused on Hepatitis C virus research (7 papers), HIV/AIDS drug development and treatment (7 papers) and Hepatitis B Virus Studies (3 papers). Eric Mabery collaborates with scholars based in United States, Czechia and Italy. Eric Mabery's co-authors include David S. Schneider, I‐hung Shih, Richard L. Mackman, Michal Hocek, Peter Šilhár, Radek Pohl, Ivan Votruba, Janelle S. Ayres, Alexandre Dias Tavares Costa and John Kincaid and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Hepatology and PLoS Pathogens.

In The Last Decade

Eric Mabery

17 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Mabery United States 12 130 121 87 80 76 17 459
Olga Yu. Susova Russia 13 168 1.3× 138 1.1× 40 0.5× 77 1.0× 22 0.3× 38 473
Cihan Aydın Türkiye 10 151 1.2× 30 0.2× 15 0.2× 143 1.8× 98 1.3× 12 434
Nicholas D. Bland United Kingdom 13 216 1.7× 108 0.9× 60 0.7× 18 0.2× 121 1.6× 15 494
Pascal Kessler France 14 404 3.1× 73 0.6× 95 1.1× 73 0.9× 22 0.3× 40 682
Marie‐Jeanne Papandréou France 15 217 1.7× 79 0.7× 55 0.6× 31 0.4× 23 0.3× 23 495
Duane T. Gish United States 15 372 2.9× 205 1.7× 26 0.3× 35 0.4× 34 0.4× 22 710
Kathrin Buchholz United States 12 167 1.3× 56 0.5× 107 1.2× 67 0.8× 81 1.1× 12 674
Hirohito Haruki Switzerland 11 756 5.8× 84 0.7× 39 0.4× 89 1.1× 93 1.2× 12 989
Azmiri Sultana Canada 11 459 3.5× 58 0.5× 41 0.5× 61 0.8× 45 0.6× 15 710
Yi‐Ting Liao Taiwan 8 258 2.0× 30 0.2× 51 0.6× 16 0.2× 17 0.2× 19 476

Countries citing papers authored by Eric Mabery

Since Specialization
Citations

This map shows the geographic impact of Eric Mabery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Mabery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Mabery more than expected).

Fields of papers citing papers by Eric Mabery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Mabery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Mabery. The network helps show where Eric Mabery may publish in the future.

Co-authorship network of co-authors of Eric Mabery

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Mabery. A scholar is included among the top collaborators of Eric Mabery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Mabery. Eric Mabery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Humphries, Paul S., John Kincaid, Eric Mabery, et al.. (2017). Carbazole-containing amides and ureas: Discovery of cryptochrome modulators as antihyperglycemic agents. Bioorganic & Medicinal Chemistry Letters. 28(3). 293–297. 36 indexed citations
2.
Humphries, Paul S., John Kincaid, Eric Mabery, et al.. (2015). Carbazole-containing sulfonamides and sulfamides: Discovery of cryptochrome modulators as antidiabetic agents. Bioorganic & Medicinal Chemistry Letters. 26(3). 757–760. 57 indexed citations
3.
Dvory‐Sobol, Hadas, Christian Voitenleitner, Eric Mabery, et al.. (2014). Clinical and In Vitro Resistance to GS-9669, a Thumb Site II Nonnucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase. Antimicrobial Agents and Chemotherapy. 58(11). 6599–6606. 8 indexed citations
4.
5.
Fenaux, Martijn, Guofeng Cheng, Eric Mabery, et al.. (2011). 1205 GS-6620, A NOVEL ANTI-HEPATITIS C VIRUS NUCLEOTIDE PRODRUG, HAS A HIGH BARRIER TO RESISTANCE IN VITRO. Journal of Hepatology. 54. S476–S476. 3 indexed citations
6.
Xu, Lianhong, Lijun Zhang, Robert J. Jones, et al.. (2011). SAR studies on dihydropyrimidinone antibiotics. Bioorganic & Medicinal Chemistry Letters. 21(6). 1670–1674. 8 indexed citations
7.
Mabery, Eric & David S. Schneider. (2010). The <i>Drosophila</i> TNF Ortholog Eiger Is Required in the Fat Body for a Robust Immune Response. Journal of Innate Immunity. 2(4). 371–378. 36 indexed citations
8.
Paulson, Matthew, Huiling Yang, I‐hung Shih, et al.. (2009). Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus. Antiviral Research. 83(2). 135–142. 18 indexed citations
9.
Vliegen, Inge, Jan Paeshuyse, Tine De Burghgraeve, et al.. (2009). Substituted imidazopyridines as potent inhibitors of HCV replication. Journal of Hepatology. 50(5). 999–1009. 35 indexed citations
10.
Kuchař, Martin, Michal Hocek, Radek Pohl, et al.. (2007). Synthesis, cytostatic, and antiviral activity of novel 6-[2-(dialkylamino)ethyl]-, 6-(2-alkoxyethyl)-, 6-[2-(alkylsulfanyl)ethyl]-, and 6-[2-(dialkylamino)vinyl]purine nucleosides. Bioorganic & Medicinal Chemistry. 16(3). 1400–1424. 16 indexed citations
11.
Šilhár, Peter, Michal Hocek, Radek Pohl, et al.. (2007). Synthesis, cytostatic and anti-HCV activity of 6-(N-substituted aminomethyl)-, 6-(O-substituted hydroxymethyl)- and 6-(S-substituted sulfanylmethyl)purine nucleosides. Bioorganic & Medicinal Chemistry. 16(5). 2329–2366. 21 indexed citations
12.
Vliegen, Inge, Jan Paeshuyse, Eric Mabery, et al.. (2007). GS-9190, a novel substituted imidazo-pyridine analogue, is a potent inhibitor of hepatitis C virus replication in vitro and remains active against known drug-resistant mutants. 8 indexed citations
13.
Schneider, David S., Janelle S. Ayres, Stephanie M. Brandt, et al.. (2007). Drosophila eiger Mutants Are Sensitive to Extracellular Pathogens. PLoS Pathogens. 3(3). e41–e41. 83 indexed citations
14.
15.
Vliegen, Inge, Betty Peng, Hao Yang, et al.. (2007). Mechanistic characterization of GS-9190, a novel non-nucleoside inhibitor of HCV NS5B polymerase with potent antiviral activity and a unique mechanism of action. 12 indexed citations
16.
Hocek, Michal, Peter Šilhár, I‐hung Shih, Eric Mabery, & Richard L. Mackman. (2006). Cytostatic and antiviral 6-arylpurine ribonucleosides. Part 7: Synthesis and evaluation of 6-substituted purine l-ribonucleosides. Bioorganic & Medicinal Chemistry Letters. 16(20). 5290–5293. 39 indexed citations
17.
Gibbs, Craig S., et al.. (2002). Characterization of a novel antibacterial agent that inhibits bacterial translation. RNA. 8(9). 1120–1128. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olga Yu. Susova Breakdown of academic impact, for papers by Cihan Aydın Breakdown of academic impact, for papers by Nicholas D. Bland Breakdown of academic impact, for papers by Pascal Kessler Breakdown of academic impact, for papers by Marie‐Jeanne Papandréou Breakdown of academic impact, for papers by Duane T. Gish Breakdown of academic impact, for papers by Kathrin Buchholz Breakdown of academic impact, for papers by Hirohito Haruki Breakdown of academic impact, for papers by Azmiri Sultana Breakdown of academic impact, for papers by Yi‐Ting Liao
Rankless by CCL
2026